Katelin buys IVV 196.07: A stronger dollar has already been blamed for weaker revenues at multinational companies over the past few quarters.

The iShares Nasdaq Biotechnology ETF dropped as much as 7%, but pared losses to finish 3.6% lower. The Nasdaq Composite ended the day down 32.90 points, or 0.7%, at 4,748.36, weighed down by sinking biotech stocks. The Dow Jones Industrial Average eked out a small gain, adding 13.76 points, or less than 0.1%, to 16,790.19, with nearly half of the blue-chip companies finishing higher. Health-care sector led losers, falling 2.3%, while energy and materials followed rising oil prices higher. The S&P 500 closed 7.13 points, or 0.4%, lower at 1,979.92, with seven of its 10 main sectors closing lower.


Genevieve:
To start, the index bottomed last week at 1,871, just above major support at the August low.

Talisha:
Looking elsewhere, the Dow Jones Industrial Average has knifed from major support, rising to its 50-day moving average.

Arletta:
On this wider view, the Nasdaq continues to whipsaw through less-charted territory.

Arlinda:
Here again, the index has spiked from major support, rising to two-week highs.

Halina:
As illustrated, the S&P has knifed from major support, rising to two-week highs.

Florencia:
The iShares junk bond ETF is up 1.2% on Monday, at $83.44. Still, Mr.

Vickie:
The yield on the U.S. 10-year Treasury note is up to 2.06%, from 1.989 last week.

Zaida:
It close at 1995 on the Sept. 16 and appeared poised to get back over 2000, but that rally was also snuffed.

Lasandra:
It again rose near that level in mid-September.

Tinisha:
At the end of August, The S&P 500 rebounded off its Aug. 24 lows in late August, and climbed as high as 1989 before pulling back.

S&P 500 Index Ishares (AMEX:IVV)
//stockhand.net/us/?q=amex%3Aivv&id=732504